CPI-455
Kurzübersicht für CPI-455 (ABIN7233243)
Applikation
Chemical Name
-
-
Verwendungszweck
- Lysine demethylase KDM5 inhibitor
-
Produktmerkmale
- CPI-455 (1628208-23-0) is a potent (IC50 = 10 nM) and selective inhibitor of the lysine demethylase KDM5 (equal inhibition of KDM5A, 5B, 5C). CPI-455 reduced the number of drug-tolerant persister cancer cells (DTPs) in a dose-dependent, KDM5-dependent manner in multiple cell lines treated with standard chemotherapy or targeted agents. CPI-455 synergized with 5-aza-2'-deoxycytidine (DAC) to reduce the viability of luminal breast cancer cells in vitro. KDM5 demethylases have recently been shown to repress the immune response to tumors via suppression of STING.
-
Reinheit
- >98 %
-
Formel
- C16H14N4O
-
Löslichkeit
- Soluble in DMSO (up to at least 25 mg/ml)
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Powder
-
Lagerung
- -20 °C
-
-
-
Hintergrund
- Epigenetics,Chromatin,Protein demethylase,STING,Immunology,Cancer,Posttranslational modification,Cytokine
-
Molekulargewicht
- 278.32
-
CAS-Nummer
- 1628208-23-0
-
-